Leukemia Clinical Trials in North Carolina

Showing 401-420 of 1,759 trials

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT05520099

The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

ImmunotherapyCancerBladder Cancer+16 more

Elephas416 participantsStarted Jun 2023

Little Rock, Arkansas, United States • Salinas, California, United States • Orlando, Florida, United States +9 more locations

Not Yet Recruiting46 miles

Study of Oral Food Challenge Biomarkers (SAFER)

NCT07279467

This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that might show if someone will have a reaction to peanut during a feeding test. The trial will enroll children ages 12 months to17 years old who are suspected of having an allergy to peanut. The primary objective is to identify a biomarker (or a combination of biomarkers) that will predict oral food challenge (OFC) (feeding test) results for participants with suspected peanut allergy.

Allergy

National Institute of Allergy and Infectious Diseases (NIAID)500 participantsStarted Apr 2026

Little Rock, Arkansas, United States • Palo Alto, California, United States • Chicago, Illinois, United States +7 more locations

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Study of Oral Food Challenge Biomarkers (SAFER)

Leukemia Trials in Other Cities

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

UNITY VCS Vitreoretinal Surgery

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

Other Conditions in North Carolina